Status:
COMPLETED
Cohort Study of Patients Treated for Peripheral Arterial Occlusive Disease
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Peripheral Arterial Obstructive Disease
Eligibility:
All Genders
18+ years
Brief Summary
Peripheral Arterial Occlusive Disease is associated with a high risk of cardiovascular events. The critical ischemia stage represents the most severe stage of Peripheral Arterial Occlusive Disease, as...
Eligibility Criteria
Inclusion
- Patient whose age ≥ 18 years
- Patient with intermittent / intermittent claudication / arterial ulcer / mixed ulcer / critical ischemia / acute ischemia, whose need for a revascularization procedure in the patient's medical management was discussed and confirmed as a multidisciplinary staff between 1st November 2013 and September 2018
- endovascular revascularized Patient
- Francophone patients
Exclusion
- Patients under guardianship or curatorship
- Patients deprived of their liberty
- Patients who oppose the use of their data for this research
Key Trial Info
Start Date :
January 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 6 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04114838
Start Date
January 2 2020
End Date
May 6 2022
Last Update
May 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014